跳至主要内容
临床试验/NCT03246893
NCT03246893已完成不适用

Efficacy of High Flow Oxygen Nasal Cannula Versus Noninvasive Positive Pressure Ventilation After Extubation in Sepsis Patients

Mahidol University2 个研究点 分布在 1 个国家目标入组 222 人开始时间: 2017年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
222
试验地点
2
主要终点
Device failure rate

研究概览

简要总结

Post extubation respiratory failure occur in 30% of extubated patients. More than 50% of them required reintubation. Noninvasive positive pressure ventilation (NIV) had been reported as an effective tool to prevent post extubation respiratory failure. Recently, high flow oxygen nasal cannula (HFNC) had been successfully used to prevent post extubation respiratory failure and prevent reintubation in comparable with NIV among post cardiothoracic surgery and high risk for reintubated patients. There was no information about HFNC versus NIV in prevention of reintubation among severe sepsis or septic shock patients.

详细描述

Post extubation respiratory failure occur in 30% of extubated patients. More than 50% of them required reintubation. Noninvasive positive pressure ventilation (NIV) had been reported as an effective tool to prevent post extubation respiratory failure. Recently, high flow oxygen nasal cannula (HFNC) had been successfully used to prevent post extubation respiratory failure and prevent reintubation. The results from recent randomized controlled trials, comparing HFNC with NIV for prevent post extubation respiratory failure among post cardiac surgery and high risk patients, showed no significant different in the treatment outcome.comparable with NIV among post cardiothoracic surgery and high risk for reintubated patients.

About 40-85% of severe sepsis/septic shock patients developed acute respiratory failure, required endotracheal intubation. According to the nature of patients population, usually eldery, multiple co-morbid condition and high APACHE II score, sepsis patients were considerred as high risk for reintubation, after extubated. There was no information about HFNC versus NIV in prevention of reintubation among severe sepsis or septic shock patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of sepsis or septic shock according to the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
  • Depended on mechanical ventilator for more than 48 hours
  • Plan for extubation due to successful weaning

排除标准

  • Patient with tracheostomy
  • Recent upper abdominal surgery
  • Wound at face that prohibit face-mask application
  • Patient or 1st degree relative not agree to participate trial
  • Physician prefer either NIV or HFNC for the patient

结局指标

主要结局

Device failure rate

时间窗: an average of 1 year

Device failure to prevent reintubation, patient discomfort, change to another device within 72 hours after extubation

次要结局

  • 28 day mortality rate(Upto 28 days)
  • Hospital mortality rate(an average of 1 year)
  • Reintubation rate(an average of 1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Surat Tongyoo

Associate Professor

Mahidol University

研究点 (2)

Loading locations...

相似试验

Efficacy of HFNC Versus NIV for Prevent Reintubation... | 临床试验